Goldstein Stephen A, Thornbrough Joshua M, Zhang Rong, Jha Babal K, Li Yize, Elliott Ruth, Quiroz-Figueroa Katherine, Chen Annie I, Silverman Robert H, Weiss Susan R
Department of Microbiology, Perlman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02201-16. Print 2017 Mar 1.
Viruses in the family , within the order , are etiologic agents of a range of human and animal diseases, including both mild and severe respiratory diseases in humans. These viruses encode conserved replicase and structural proteins as well as more diverse accessory proteins, encoded in the 3' ends of their genomes, that often act as host cell antagonists. We previously showed that 2',5'-phosphodiesterases (2',5'-PDEs) encoded by the prototypical , mouse hepatitis virus (MHV), and by Middle East respiratory syndrome-associated coronavirus antagonize the oligoadenylate-RNase L (OAS-RNase L) pathway. Here we report that additional coronavirus superfamily members, including lineage A betacoronaviruses and toroviruses infecting both humans and animals, encode 2',5'-PDEs capable of antagonizing RNase L. We used a chimeric MHV system (MHV) in which exogenous PDEs were expressed from an MHV backbone lacking the gene for a functional NS2 protein, the endogenous RNase L antagonist. With this system, we found that 2',5'-PDEs encoded by the human coronavirus HCoV-OC43 (OC43; an agent of the common cold), human enteric coronavirus (HECoV), equine coronavirus (ECoV), and equine torovirus Berne (BEV) are enzymatically active, rescue replication of MHV in bone marrow-derived macrophages, and inhibit RNase L-mediated rRNA degradation in these cells. Additionally, PDEs encoded by OC43 and BEV rescue MHV replication and restore pathogenesis in wild-type (WT) B6 mice. This finding expands the range of viruses known to encode antagonists of the potent OAS-RNase L antiviral pathway, highlighting its importance in a range of species as well as the selective pressures exerted on viruses to antagonize it. Viruses in the family include important human and animal pathogens, including the recently emerged viruses severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and Middle East respiratory syndrome-associated coronavirus (MERS-CoV). We showed previously that two viruses within the genus , mouse hepatitis virus (MHV) and MERS-CoV, encode 2',5'-phosphodiesterases (2',5'-PDEs) that antagonize the OAS-RNase L pathway, and we report here that these proteins are furthermore conserved among additional coronavirus superfamily members, including lineage A betacoronaviruses and toroviruses, suggesting that they may play critical roles in pathogenesis. As there are no licensed vaccines or effective antivirals against human coronaviruses and few against those infecting animals, identifying viral proteins contributing to virulence can inform therapeutic development. Thus, this work demonstrates that a potent antagonist of host antiviral defenses is encoded by multiple and diverse viruses within the family , presenting a possible broad-spectrum therapeutic target.
冠状病毒科病毒属于套式病毒目,是一系列人类和动物疾病的病原体,包括人类的轻度和重度呼吸道疾病。这些病毒编码保守的复制酶和结构蛋白,以及在其基因组3'端编码的更多样化的辅助蛋白,这些辅助蛋白通常充当宿主细胞拮抗剂。我们之前表明,由典型的小鼠肝炎病毒(MHV)以及中东呼吸综合征相关冠状病毒编码的2',5'-磷酸二酯酶(2',5'-PDEs)可拮抗寡腺苷酸-RNase L(OAS-RNase L)途径。在此我们报告,其他冠状病毒超家族成员,包括感染人类和动物的A类β冠状病毒和环曲病毒,也编码能够拮抗RNase L的2',5'-PDEs。我们使用了一种嵌合MHV系统(MHV),其中外源性PDEs由缺乏功能性NS2蛋白(内源性RNase L拮抗剂)基因的MHV骨架表达。利用该系统,我们发现人类冠状病毒HCoV-OC43(OC43;普通感冒病原体)、人类肠道冠状病毒(HECoV)、马冠状病毒(ECoV)和马环曲病毒伯尔尼株(BEV)编码的2',5'-PDEs具有酶活性,可拯救MHV在骨髓来源巨噬细胞中的复制,并抑制这些细胞中RNase L介导的rRNA降解。此外,OC43和BEV编码的PDEs可拯救MHV复制并恢复野生型(WT)B6小鼠的发病机制。这一发现扩大了已知编码强效OAS-RNase L抗病毒途径拮抗剂的病毒范围,突出了其在一系列物种中的重要性以及病毒对抗该途径所面临的选择压力。冠状病毒科病毒包括重要的人类和动物病原体,包括最近出现的严重急性呼吸综合征相关冠状病毒(SARS-CoV)和中东呼吸综合征相关冠状病毒(MERS-CoV)。我们之前表明,属内的两种病毒,小鼠肝炎病毒(MHV)和MERS-CoV,编码拮抗OAS-RNase L途径的2',5'-磷酸二酯酶(2',5'-PDEs),我们在此报告,这些蛋白在其他冠状病毒超家族成员中也具有保守性,包括A类β冠状病毒和环曲病毒,这表明它们可能在发病机制中起关键作用。由于目前尚无针对人类冠状病毒的许可疫苗或有效抗病毒药物,针对感染动物的冠状病毒的此类药物也很少,因此鉴定有助于毒力的病毒蛋白可为治疗开发提供信息。因此,这项工作表明,宿主抗病毒防御的一种强效拮抗剂由冠状病毒科内多种不同病毒编码,这提供了一个可能的广谱治疗靶点。